Navigation Links
Arable Corporation Announces New Technology for Clinical Trial Industry
Date:10/11/2010

PALO ALTO, Calif., Oct. 11 /PRNewswire/ -- Arable Corporation (www.arablecorp.com) has announced the launch of Arable Perform to bring unique CTMS technologies to the clinical trial industry.  Whereas traditional CTMS systems have been costly and require months to implement, Perform brings CTMS and EDC capabilities without the traditionally high start-up costs.

The Arable Perform platform allows Sponsors or CROs to manage the planning and implementation of multiple trials simultaneously.  Perform also provides large Sites with the ability to manage their service delivery to multiple CROs or Sponsors.  With Perform's proprietary dashboard, stakeholders and managers are able to view real-time status of trials down to the site or subject visit.

"Our new Arable Perform platform allows us to offer our clients immediate access to clinical trial software with the shortest "Go Live" time in the industry and at a reasonable cost," stated Ary Sarkar, CEO of Arable Corporation.  "At Arable, we combine our knowledge of the clinical trial space with our technology partnerships to offer our clients a range of services from trial planning and implementation through regulatory submittal."

Arable brings a suite of services to offer the pharmaceutical and biotech industries.  With the addition of the Perform platform, Arable introduces CTMS and EDC software to complement their existing partnerships with GlobalSubmit and Quest Life Sciences.

Arable is announcing a 30 day free trial of their Perform platform to highlight the benefits to clinical organizations.  With the economic recovery continuing to affect pharma and biotech R & D budgets, Arable believes that the Perform software will save clinical organizations money and increase time to market.  Terms and conditions apply to the free offer.

Arable Corporation combines the right technology with our proven CRO servic
'/>"/>

SOURCE Arable Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. The Results are in: Users of BodyMedias Wearable Body-Monitoring Technology Lose 3 Times More Weight
2. Frost & Sullivan Recognizes Holst Centre and imec for Its Path Breaking Wearable Energy Harvester Technology
3. Two-Year SYNTAX Data Show Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) EXPRESS(R) Stents and Bypass Surgery
4. New Overall Survival Study Results Confirm Oral Xeloda(R) plus Oxaliplatin (XELOX) is Comparable to FOLFOX-4 for the First-Line Treatment of Advanced Colorectal Cancer
5. New Phase II Data Show Safety of Once-Daily Oral Factor Xa Inhibitor, DU-176b, Comparable to Warfarin in Patients With Non-Valvular Atrial Fibrillation
6. SYNTAX Data Show Comparable Safety for Complex Patients Treated with TAXUS(R) Express2(TM) Stents and Bypass Surgery
7. Video: Large, Multi-Center Trial Demonstrates Comparable Accuracy for Virtual Colonoscopy and Standard Colonoscopy
8. MultiVu Video Feed: Major Trial Demonstrates Comparable Accuracy of Virtual Colonoscopy and Standard Colonoscopy
9. Preliminary Results of Randomized Pilot Study Show Comparable Efficacy for OrbusNeichs Genous(TM) Bio-engineered R Stent(TM) and Boston Scientifics Taxus(R) Stent in Patients at High Risk of Restenosis
10. Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2011 Earnings Release Date and Teleconference
11. Medical Simulation Corporation Signs Agreement With a Nationally Ranked Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Colo. , Jan. 22, 2015  BiOptix is pleased ... as Vice President of Chemistry and Biochemistry. Scott joins ... Pharmaceuticals, AstraZeneca Pharmaceuticals, and Amgen throughout the course of ... development. "Scott is a nationally recognized thought ...
(Date:1/22/2015)... , Jan. 22, 2015 /PRNewswire/ - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ... focus on Omega-3 therapies for cardiovascular disease and overall health ... Company,s accomplishments in 2014 and its outlook for 2015 from ... Fellow Shareholders, We would like to take this ...
(Date:1/22/2015)...  Profil Institute for Clinical Research, Inc., a clinical research ... a new textbook,  Translational Research Methods for Diabetes, Obesity ... global scientific publisher. The textbook is the ... in early phase clinical studies of new drugs for ...
Breaking Medicine Technology:BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2Pivotal Therapeutics: Year in Review and CEO Update 2Pivotal Therapeutics: Year in Review and CEO Update 3Pivotal Therapeutics: Year in Review and CEO Update 4Pivotal Therapeutics: Year in Review and CEO Update 5Pivotal Therapeutics: Year in Review and CEO Update 6Pivotal Therapeutics: Year in Review and CEO Update 7New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 2New Textbook "Translational Research Methods for Diabetes, Obesity and Cardiometabolic Drug Development" Provides Critical Review Of Current And Emerging Clinical Investigation Methods 3
... (Nasdaq: OPTR ) today announced that the Company ... June 8, 2011 at 11:00 a.m. Eastern Time at The ... http://photos.prnewswire.com/prnh/20090413/LA97352LOGO ) A live audio webcast of this ... Company,s website at www.optimerpharma.com . Replays of this presentation ...
... Va., June 1, 2011 Mirixa Corporation is pleased ... a licensing agreement for MirixaEdge(SM), a clinical application that ... Medication Therapy Management (MTM). Family Physicians Group ... One Source Pharmacy and selected it as FPG,s preferred ...
Cached Medicine Technology:Optimer Pharmaceuticals to Present at the Jefferies 2011 Global Healthcare Conference 2MirixaEdge(SM) to be Licensed by One Source Pharmacy, LLC 2MirixaEdge(SM) to be Licensed by One Source Pharmacy, LLC 3
(Date:1/22/2015)... 22, 2015 Deer Path of Huntley ... Valentine’s Day Happy Hour from 3 p.m. to 4 p.m. on ... Parkway in Huntley, Illinois, serves adults with physical disabilities between the ... include Valentine's Day treats, games and sweetheart-themed karaoke. , For more ...
(Date:1/22/2015)... its top dressmaking technologies, has been a leading dress supplier ... latest designs of wedding dresses and launching a site-wide promotion ... the fresh new products are designed for 2015, and they ... All the clothes from LunaDress follow up with the latest ...
(Date:1/22/2015)... January 22, 2015 Gabe’s Chemo Duck Program is ... the first app ever created for kids with cancer. The Chemo ... and devices, is filled with enjoyable games to help children of ... The free app helps to keep kids entertained, educated and at ...
(Date:1/22/2015)... The Incredible Bulk is a revolutionary method put together ... by up to 30lbs in less than 12 weeks without ... Stevenson, prompting an investigative review. , “Our Incredible Bulk ... formula that allows the body to pack on a massive ...
(Date:1/22/2015)... AngelWeddingDress, the premier women’s dress supplier, has ... View website of AngelWeddingDress.com to find more ... dresses online for a bridal party. AngelWeddingDress offers a ... them. Its maternity wedding dresses are specially designed for ...
Breaking Medicine News(10 mins):Health News:Deer Path of Huntley Affordable Assisted Living to Host Valentine's Day Happy Hour 2Health News:LunaDress Shows The Latest Styles Of Wedding Dresses In 2015 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 2Health News:Chemo Duck Launches First App Ever Created for Kids with Cancer 3Health News:The Incredible Bulk: Review Examining Ben Pakulski’s Brand New Bulking Muscle Building Diet Program Released 2Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2
... Reporter , TUESDAY, July 20 (HealthDay News) -- The ... chemotherapy, is safe and can effectively treat an advanced ... researchers report. Previously it had been thought that ... life-threatening bleeding, for patients with non-squamous non-small-cell lung tumors. ...
... New Haven, onn. - A team of Yale researchers have identified ... ovarian cancer, a hard to detect and often deadly form of ... journal Cancer Research, the team showed that a variant ... ovarian cancer patients. In addition, this variant was found in 61 ...
... Those ubiquitous wires connecting listeners to you-name-the-sounds from invisible ... more likely today, Lady Gaga -- only hint at ... Now a data-driven review by Northwestern University researchers ... Reviews Neuroscience pulls together converging research from the ...
... the Law Center and Graduate College of Social Work ... Student of the Year by the National Association of Social ... 9 at the organization,s annual conference at the Westin Galleria ... graduate or undergraduate student enrolled in a social work program ...
... COLUMBIA, Mo. ... illicit drug use among all ethnic groups. Although previous ... factors can reduce their risk for substance abuse, this ... findings from a University of Missouri study reveal that ...
... Conference in Vienna are charging developed and developing country ... of people in need of lifesaving HIV treatment. ... the International Treatment Preparedness Coalition,s (ITPC), latest report, Rationing ... pullback on AIDS commitment and funding: caps on the ...
Cached Medicine News:Health News:Avastin Largely Safe for Patients With Type of Advanced Lung Cancer 2Health News:Avastin Largely Safe for Patients With Type of Advanced Lung Cancer 3Health News:Avastin Largely Safe for Patients With Type of Advanced Lung Cancer 4Health News:Yale scientists discover new genetic marker of ovarian cancer risk 2Health News:Taking music seriously 2Health News:Taking music seriously 3Health News:University of Houston's Meghan Baker named Social Work Student of the Year in Texas 2Health News:Healthy families, religious involvement buffer youth against risk factors related to drug abuse 2Health News:Writing checks that bounce: World continues to backtrack on HIV treatment 2Health News:Writing checks that bounce: World continues to backtrack on HIV treatment 3Health News:Writing checks that bounce: World continues to backtrack on HIV treatment 4Health News:Writing checks that bounce: World continues to backtrack on HIV treatment 5
... A particular challenge in transseptal left heart ... must be exchanged for a sheath with ... wall position. Traditionally, such an exchange has ... heparinized patient. Biosense Webster has overcome this ...
... of guiding introducers includes Swartz™ Series, ... piece steerable, all designed for the ... varying curves and longer sheath lengths ... Jude Medical guiding introducers are designed ...
Novus 30001 A fully-integrated and powerful 532 nm Operating Room Photocoagulator with reliable DPSS technology and simplified operation using a touch screen interface and remote control....
... 1064 nm Nd:YAG Base Platform ... ophthalmologists treating the anterior segment ... the elimination of secondary cataracts ... Selecta platform offers multiple upgrade ...
Medicine Products: